Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
12 studies found for:    Open Studies | "Cholera"
Show Display Options
Rank Status Study
1 Recruiting Introduction of Cholera Vaccine in Bangladesh
Condition: Cholera
Interventions: Biological: ShanChol;   Behavioral: Vaccine and behaviour
2 Recruiting Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh
Condition: Cholera
Interventions: Biological: Shanchol;   Biological: Placebo
3 Recruiting Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts
Conditions: Cholera;   Diarrhea
Intervention:
4 Recruiting Cholera Vaccine Investment Strategy in Bangladesh
Condition: Cholera
Intervention: Biological: Shanchol
5 Unknown  Immunity to Human Cholera in Bangladesh
Condition: Cholera
Intervention:
6 Not yet recruiting Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants
Conditions: Cholera;   Diarrhea;   Vibrio Infections
Interventions: Biological: Bivalent killed oral cholera vaccine;   Biological: Killed Escherichia coli K12 placebo
7 Unknown  Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine
Condition: Cholera
Intervention:
8 Not yet recruiting Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine
Condition: Cholera
Interventions: Biological: Cholvax;   Biological: Shanchol
9 Not yet recruiting Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine
Condition: Cholera
Interventions: Biological: HL-OCV;   Biological: Shanchol
10 Recruiting Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi
Conditions: Miscarriage;   Stillbirth;   Cholera
Interventions: Biological: Shanchol;   Other: Non-intervention
11 Not yet recruiting Safety and Immunogenicity of a New Formulation of Euvichol®
Condition: Cholera
Interventions: Biological: Test Oral Cholera Vaccine;   Biological: Euvichol®
12 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:

Indicates status has not been verified in more than two years